Companies / AgomAb Therapeutics NV
AgomAb Therapeutics NV
Nasdaq: AGMBCIK 2020932ANTWERPEN
Ownership
34.2M shares outstanding
Ownership
| 10%+ / strategic | 14.26% | 4,873,680 |
| Institutions | 15.34% | 5,239,857 |
| Public float | 70.40% | 24,053,631 |
% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 11
View all →| Insider | % of shares | Shares |
|---|---|---|
Bond Colin MichaelDirector | — | — |
Borderias Andrea SaezChief Development Officer | — | — |
Epstein David RDirector | — | — |
Hammer OhadDirector | — | — |
Jahreis Angelika MarthaDirector | — | — |
Kemula Pierre Thadee VictorChief Financial Officer | — | — |
Knotnerus Tim JasperCEOChief Executive Officer · Director | — | — |
Lefever EllenGeneral Counsel | — | — |
van der Horst Paul HenrykChief Business Officer | — | — |
Verduyn-van Weegen Felice IsabelDirector | — | — |
Institutional holders 9
View all →| Holder | Value | % of shares |
|---|---|---|
| $29.19M | 8.15% | |
| $16.97M | 4.74% | |
| $6.29M | 1.76% | |
| $999.0K | 0.28% | |
| $524.5K | 0.15% | |
| $477.3K | 0.13% | |
| $265.6K | 0.06% | |
| $160.8K | 0.04% | |
| $149.4K | 0.04% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).No activity matches these filters.
5%+ ownership events
Schedule 13D / 13G
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| AGMB | — | 00860C102 |